Pharma Technology Focus: the dengue dilemma
In this issue: dengue fever vaccine controversy, the problem of manipulated data, fixing...
Focus:
-
![]()
‘Gene-ie in a bottle’ gene therapy opportunity is a treasure trove but CMOs lack capacity
-
![]()
‘Painful’ 2020 Russian regulations will make EU rules ‘look like a walk in the park’
-
![]()
Pfizer’s Upjohn and Mylan merger set to create drug and manufacturing juggernaut
-
![]()
Andhra Pradesh and Telangana: Indian contract manufacturing powerhouses for US API supply
-
![Achilles personalised cell therapies]()
Personalised cell therapy developer Achilles closes £100m round
-
![]()
The Ferrari of medical machinery: How one solution impressed Arimpek
Most Read
- Pharma Technology Focus: the dengue dilemma
- Personalised cell therapy developer Achilles closes £100m round
- The Ferrari of medical machinery: How one solution impressed Arimpek
- Novartis defends Zolgensma in face of FDA’s data concerns
- Targeting MND-causing genetic mutations to support drug development
Company A-Z
Latest Content
Stability Testing Blister Packs Inspected with Sepha’s VisionScan
This white paper will test the hypothesis that the VisionScan is considered non-destructive.
AstraZeneca to boost R&D efforts in China
UK-based AstraZeneca is set to support global research and development (R&D) efforts towards new medications with the creation of two centres and an investment fund in China.
Partnerships with CDMOs will be a key growth driver for gene therapy
Companies that develop gene-based therapies often need to think in advance about how they want to develop a product, including the decision of whether to invest in a manufacturing facility or CDMO.
Quali®-V-I Hard Two-Piece HPMC Capsules for Inhalation
Inhalation delivery offers significant and unique benefits in the treatment of a variety of illnesses.
Tripharm’s Pharmaceutical Manufacturing Centre, North Carolina
TriPharm Services, a contract development and manufacturing organisation (CDMO), is developing a pharmaceutical manufacturing centre in Morrisville, North Carolina, US.
Pharma Technology Focus: the dengue dilemma
In this issue: dengue fever vaccine controversy, the problem of manipulated data, fixing a broken drug patent system, non-hormonal menopause treatments and much more.
‘Gene-ie in a bottle’ gene therapy opportunity is a treasure trove but CMOs lack capacity
CMOs are recognising the coming demand for gene therapies and have started to build production capacity, but compared with other biologic therapies there are far fewer gene therapy contract manufacturing sites worldwide.
Product Design and Identity Development of a New Precision Tool
Every year some 13.5 million dental implants are placed worldwide, 95% of them “by hand”.
Managing Analytical Methods Across all Stages of their Lifecycle
Chromatographic modelling using DryLab®4 software from Molnár Institute saves time and resources across all three stages of the lifecycle of an analytical method.
Sanofi’s Digital Manufacturing Facility, Massachusetts
Sanofi, a biopharmaceutical company based in France, opened a digital biopharmaceutical manufacturing facility in Framingham, Massachusetts, US, in October 2019.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top
